To further investigate the changes in FH glycosylation during SP-HUS, we evaluated the glycosylation status of FH in four SP-HUS patients during the acute phase and remission using LC-MS/MS glycopeptide profiling and compared it to healthy controls. The gene discussed is FH; the disease is hemolytic-uremic syndrome.